Posts by: Ana Pamplona, PhD

News

Researchers from The Weizmann Institute of Science in Rehovot, Israel, identified a new treatment that can prevent lung cancer cells from developing resistance to chemotherapy in mice. The study entitled ... Read more

June 3, 2015

PROCLAIM Trial Data on Non-Small Cell Lung Cancer Presented at ASCO Annual Meeting

News

During the American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, Eli Lilly and Company presented the final data of the Phase III PROCLAIM trial. This study compared the overall survival ... Read more

May 29, 2015

Smokers’ Lung Cancer Risk Profile Altered By Genetic Information, Increases CT Lung Screening

News

New research on lung cancer revealed that adding genetic information to previous or current smokers’ clinical risk profile leads to a reclassification of the risk of developing lung cancer in ... Read more

April 28, 2015April 28, 2015

miR-34a Shown To Be a Promising Target In Lung Cancer Therapy

News

Researchers from The University of Texas MD Anderson Cancer Center have uncovered the mechanism by which the tumor suppressor gene p53 regulates the molecule programmed cell death protein 1 (PD-L1) in small cell ... Read more

March 31, 2015March 31, 2015

The Retinoblastoma Gene – An “Old” Cancer Gene With a Novel Function

Lung cancer News, News

Researchers from The Institute of Cancer Research, London and UCL (University College London) revealed a previously unknown function for an old cancer gene, the retinoblastoma gene: “gluing” broken strands ... Read more

February 26, 2015February 26, 2015

Parkinson Gene Associated With Familial Lung Cancer

News

A collaborative work between researchers from the Medical College of Wisconsin (MCW) and the Genetic Epidemiology of Lung Cancer Consortium (GELCC) identified a gene that links early-onset Parkinson’s disease ... Read more

February 20, 2015February 20, 2015

Rare and Classic EGFR Mutations in NSCLC Have Distinct Responses to Therapy, According To New Study

News

Lung cancer is divided in two major groups: small-cell lung cancer and non-small cell lung cancer (NSCLC), with prognosis for NSCLC patients still rated as very poor. Although improvements ... Read more

December 5, 2014December 5, 2014

Study Analyzes Osteopontin For Prognostic Information In Radiotherapy of NSCLC

News

A new study entitled “Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer” was published on BMC Cancer by Dr. Christian Ostheimer, Department of Radiation ... Read more

October 13, 2014October 13, 2014

‘Achilles Heel’ in Metabolic Pathway Could Lead to New Lung Cancer Treatments, According to Study

News

A novel study on lung cancer, entitled “Inhibition of Cancer Cell Proliferation by PPARγ Is Mediated by a Metabolic Switch that Increases Reactive Oxygen Species Levels” published in the ... Read more

October 6, 2014October 6, 2014

Dabrafenib Shows Promising Results in Non-Small-Cell Lung Cancer

News

During the European Society for Medical Oncology (ESMO) 2014 Congress held in Madrid in September, two studies were presented concerning promising therapies against subsets of Non-Small-Cell Lung Cancer (NSCLC). The ... Read more